Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis (original) (raw)

• Corbett, E.L. et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163, 1009–1021 (2003).
  Article Google Scholar
• Cole, S.T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537–544 (1998).
  Article CAS Google Scholar
• Smith, I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Micro. Rev. 16, 463–496 (2003).
  Article CAS Google Scholar
• Young, D.B. Ten years of research progress and what's to come. Tuberculosis (Edinb) 83, 77–81 (2003).
  Article Google Scholar
• Jacobs, W.R. Jr. in Molecular Genetics of Mycobacteria (ed. Hatfull, G.F. & Jacobs, W.R. Jr.) 1–19 (ASM Press, Washington D.C., 2000).
  Google Scholar
• Barnes, P.F., Modlin, R.L. & Ellner, J.J. in Tuberculosis; pathogenesis, protection and control (ed. Bloom, B.R.) 417–430 (ASM Press, Washington D.C., 1994).
  Google Scholar
• Dannenberg, A.M. & Rook, G.A.W. in Tuberculosis pathogenesis, protection, and control (ed. Bloom, B.R.) 459–483 (ASM Press, Washington, DC, 1994).
  Google Scholar
• Flynn, J.L. & Chan, J. Immunology of tuberculosis. Ann. Rev. Immunol. 19, 93–129 (2001).
  Article CAS Google Scholar
• Doffinger, R. et al. Inherited disorders of IL-12- and IFN-γ-mediated immunity: a molecular genetics update. Mol. Immunol. 38, 903–909. (2002).
  Article CAS Google Scholar
• Fieschi, C. et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor β1 deficiency: medical and immunological implications. J. Exp. Med. 197, 527–535 (2003).
  Article CAS Google Scholar
• Lichtenauer-Kaligis, E.G. et al. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor β1 deficient patients and evidence for the existence of partial IL-12 receptor β1 deficiency. Eur. J. Immunol. 33, 59–69 (2003).
  Article CAS Google Scholar
• Armstrong, J.A. & Hart, P.D. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J. Exp. Med. 134, 713–740 (1971).
  Article CAS Google Scholar
• Xu, S. et al. Intracellular trafficking in Mycobacterium tuberculosis and _Mycobacterium avium_-infected macrophages. J. Immunol. 153, 2568–2578 (1994).
  CAS PubMed Google Scholar
• Schlesinger, L.S., Bellinger-Kawahara, C.G., Payne, N.R. & Horwitz, M.A. Phagocytosis of Mycobacterium tuberculosis is mediated by monocyte complement receptors and complement C3. J. Immunol. 144, 2771–2780 (1990).
  CAS PubMed Google Scholar
• Wright, S.D. & Silverstein, S.C. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J. Exp. Med. 161, 2016–2023 (1983).
  Article Google Scholar
• Zimmerli, S., Edwards, S. & Ernst, J.D. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Amer. J. Resp. Cell. Mol. Biol. 15, 760–770 (1996).
  Article CAS Google Scholar
• Jackett, A.S., Aber, V.R. & Lowrie, D.B. Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. J. Gen. Micro. 104, 37 (1978).
  Article CAS Google Scholar
• Middlebrook, G. Amer. Rev. Tubercul. 69, 471–472 (1954).
  CAS Google Scholar
• Hickman, S.P., Chan, J. and Salgame, P. Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J. Immunol. 168, 4636–4642 (2002).
  Article CAS Google Scholar
• Nau, G.J. et al. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 99, 1503–1508 (2002).
  Article CAS Google Scholar
• Noss, E.H., Harding, C.V. & Boom, W.H. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell. Immunol. 201, 63–74 (2000).
  Article CAS Google Scholar
• Ting, L.-M., Kim, A.C., Cattamanchi, A. & Ernst, J.D. Mycobacterium tuberculosis inhibits IFN-γ transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163, 3898–3906 (1999).
  CAS PubMed Google Scholar
• Chan, J., Fan, X., Hunter, S.W., Brennan, P.J. and Bloom, B.R. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59, 1755–1761 (1991).
  CAS PubMed PubMed Central Google Scholar
• Sly, L.M., Hingley-Wilson, S.M., Reiner, N.E. & McMaster, W.R. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J. Immunol. 170, 430–437 (2003).
  Article CAS Google Scholar
• Fine, P.E. BCG: the challenge continues. Scand. J. Infect. Dis. 33, 243–245 (2001).
  Article CAS Google Scholar
• Fine, P.E.M., Carneiro, I.A.M., Milstein, J.B. & Clemens, C.J. Issues relating to the use of BCG in immunization programmes. http://www.who.int/vaccines-documents/DocsPDF99/www9943.pdf (2002).
• Huebner, R.E. BCG vaccination in the control of tuberculosis. Curr. Top. Micro. Immun. 215, 263–282 (1996).
  CAS Google Scholar
• Hess, J. et al. Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc. Natl. Acad. Sci. USA 95, 5299–5304 (1998).
  Article CAS Google Scholar
• Horwitz, M.A., Harth, G., Dillon, B.J. & Maslesa-Galic, S. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. USA 97, 13853–13858 (2000).
  Article CAS Google Scholar
• Horwitz, M.A. & Harth, G. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect. Immun. 71, 1672–1679 (2003).
  Article CAS Google Scholar
• Pym, A.S. et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 9, 533–539 (2003).
  Article CAS Google Scholar
• Hondalus, M.K. et al. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 68, 2888–2898 (2000).
  Article CAS Google Scholar
• Jackson, M. et al. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect. Immun. 67, 2867–2873 (1999).
  CAS PubMed PubMed Central Google Scholar
• Sambandamurthy, V.K. et al. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat. Med. 8, 1171–1174 (2002).
  Article CAS Google Scholar
• Behr, M.A. & Small, P.M. Has BCG attenuated to impotence? Nature 389, 133–134 (1997).
  Article CAS Google Scholar
• Buchmeier, N. et al. A parallel intraphagosomal survival strategy shared by Mycobacterium tuberculosis and Salmonella enterica. Mol. Micro. 35, 1375–1382 (2000).
  Article CAS Google Scholar
• Pavelka, M.S.J., Chen, B., Kelley, C.L., Collins, F.M. & Jacobs, W.R. Jr. Vaccine efficacy of a lysine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 71, 4190–4192 (2003).
  Article CAS Google Scholar
• Smith, D.A., Parish, T., Stoker, N.G. & Bancroft, G.J. Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect. Immun. 69, 1142–1150 (2001).
  Article CAS Google Scholar
• Berthet, F.-X. et al. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science 282, 759–762 (1998).
  Article CAS Google Scholar
• de Mendonca-Lima, L. et al. Erp, an extracellular protein family specific to mycobacteria. Microbiology 147, 2315–2320 (2001).
  Article CAS Google Scholar
• Tullius, M.V., Harth, G. & Horwitz, M.A. Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs. Infect. Immun. 71, 3927–3936 (2003).
  Article CAS Google Scholar
• De Voss, J.J. et al. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc. Natl. Acad. Sci. USA 97, 1252–1257 (2000).
  Article CAS Google Scholar
• Hensel, M., Shea, J.E., Gleeson, C., Jones, M.D., Dalton, E. & Holden, D.W. Simultaneous identification of bacterial virulence genes by negative selection. Science 269, 400–403 (1995).
  Article CAS Google Scholar
• Camacho, L.R., Ensergueix, D., Perez, E., Gicquel, B. & Guilhot, C. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Micro. 34, 257–267 (1999).
  Article CAS Google Scholar
• Cox, J.S., Chen, B., McNeil, M. & Jacobs, W.R. Jr. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402, 79–83 (1999).
  Article CAS Google Scholar
• Perez, E. et al. An essential role for phoP in Mycobacterium tuberculosis virulence. Mol. Micro. 41, 179–187 (2001).
  Article CAS Google Scholar
• Nigou, J., Gilleron, M. & Puzo, G. Lipoarabinomannans: from structure to biosynthesis. Biochimie 85, 153–166 (2003).
  Article CAS Google Scholar
• Braunstein, M., Espinosa, B.J., Chan, J., Belisle, J.T. & Jacobs, W.R.J. SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol. Micro. 48, 453–464 (2003).
  Article CAS Google Scholar
• Hernandez-Pando, R. et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 356, 2113–2114 (2000).
  Article Google Scholar
• McCune, R. & Tompsett, R. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J. Exp. Med. 104, 737–762 (1957).
  Article Google Scholar
• McCune, R., Tompsett, R. & McDermott, W. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J. Exp. Med. 104, 763–804 (1957).
  Article Google Scholar
• Koch, R. The Aetiology of tuberculosis (ed. Pinner, D.a.M.M.) (National Tuberculosis Association, New York, 1882).
  Google Scholar
• Glickman, M.S., Cox, J.S. & Jacobs, W.R. Jr. A novel mycolic acid cyclopropane synthetase is required for coding, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell 5, 717–727 (2000).
  Article CAS Google Scholar
• McKinney, J.D. et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406, 735–738 (2000).
  Article CAS Google Scholar
• Raynaud, C. et al. Phospholipases C are involved in the virulence of Mycobacterium tuberculosis. Mol. Micro. 45, 203–217 (2002).
  Article CAS Google Scholar
• Johansen, K.A., Gill, R.E. & Vasil, M.L. Biochemical and molecular analysis of phospholipase C and phospholipase D activity in mycobacteria. Infect. Immun. 64, 3259–3266 (1996).
  CAS PubMed PubMed Central Google Scholar
• Dahl, J.L. et al. The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc. Natl. Acad. Sci. USA 100, 10026–10031 (2003).
  Article CAS Google Scholar
• Avarbock, D., Avarbock, A. & Rubin, H. Differential regulation of opposing RelMtb activities by the aminoacylation state of a tRNA.ribosome.mRNA.RelMtb complex. Biochem. 39, 11640–11648 (2000).
  Article CAS Google Scholar
• Primm, T.P. et al. The stringent response of Mycobacterium tuberculosis is required for long-term survival. J. Bacteriol. 182, 4889–4898 (2000).
  Article CAS Google Scholar
• Boshoff, H.I.M., Reed, M.B., Barry, C.E. 3rd & Mizrahi, V. DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 113, 183–193 (2003).
  Article CAS Google Scholar
• Stewart, G.R. et al. Overexpression of heat-shock proteins reduces the survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat. Med. 7, 732–737 (2001).
  Article CAS Google Scholar
• North, R.J., Ryan, L., LaCource, R., Mogues, T. & Goodrich, M.E. Growth rate of mycobacteria in mice as an unreliable indicator of mycobacterial virulence. Infect. Immun. 67, 5483–5485 (1999).
  CAS PubMed PubMed Central Google Scholar
• Kaushal, D. et al. Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc. Natl. Acad. Sci. USA 99, 8330–8335 (2002).
  Article CAS Google Scholar
• Collins, D.M. et al. Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 92, 8036–8040 (1995).
  Article CAS Google Scholar
• Steyn, A.J. et al. Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth. Proc. Natl. Acad. Sci. USA 99, 3147–3152 (2002).
  Article CAS Google Scholar
• Pethe, K. et al. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 412, 190–194. (2001).
  Article CAS Google Scholar
• Talbot, E.A., Perkins, M.D., Silva, S.F. & Frothingham, R. Disseminated bacille Calmette-Guerin disease after vaccination: case report and review. Clin. Infect. Dis. 24, 1139–1146 (1997).
  Article CAS Google Scholar
• Rosenfeldt, V., Paerregaard, A. & Valerius, N.H. Disseminated infection with Bacillus Calmette-Guerin in a child with advanced HIV disease. Scand. J. Infect. Dis. 29, 526–527 (1997).
  Article CAS Google Scholar
• Raton, J.A. et al. Disseminated bacillus Calmette-Guerin infection in an HIV-infected child: a case with cutaneous lesions. Med. J. Austr. 156, 286–287 (1992).
  Google Scholar
• Reynes, J.P.C., Lamaury, I., Janbon, F. & Bertrand, A. Bacille Calmette-Guerin adenitis 30 years after immunization in a patient with AIDS. Lancet 356, 2133–2138 (2000).
  Article Google Scholar
• Smith, E., Thybo, S. & Bennedsen, J. Infection with Mycobacterium bovis in a patient with AIDS: a late complication of BCG vaccination. Scand J. Infect. Dis. 24, 109–110 (1992).
  Article CAS Google Scholar
• McDonough, K.A. & Kress, Y. Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect. Immun. 63, 4802–4811 (1995).
  CAS PubMed PubMed Central Google Scholar
• Mueller-Ortiz, S.L. et al. Decreased infectivity despite unaltered C3 binding by a Δhbha mutant of Mycobacterium tuberculosis. Infect. Immun. 70, 6751–6760 (2002).
  Article CAS Google Scholar